These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 29908369)
41. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology. Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420 [TBL] [Abstract][Full Text] [Related]
42. Determinants of worse prognosis in patients with cardiac resynchronization therapy defibrillators. Are ventricular arrhythmias an adjunctive risk factor? Landolina M; Boriani G; Biffi M; Cattafi G; Capucci A; Dello Russo A; Facchin D; Rordorf R; Sagone A; Del Greco M; Morani G; Nicolis D; Meloni S; Grammatico A; Gasparini M J Cardiovasc Med (Hagerstown); 2022 Jan; 23(1):42-48. PubMed ID: 34392257 [TBL] [Abstract][Full Text] [Related]
43. Strong coherence between heart rate variability and intracardiac repolarization lability during biventricular pacing is associated with reverse electrical remodeling of the native conduction and improved outcome. Tereshchenko LG; Henrikson CA; Berger RD J Electrocardiol; 2011; 44(6):713-7. PubMed ID: 21944164 [TBL] [Abstract][Full Text] [Related]
44. Relationship of quantitative parameters of myocardial perfusion SPECT and ventricular arrhythmia in patients receiving cardiac resynchronization therapy. Hou PN; Tsai SC; Lin WY; Cheng CM; Chiang KF; Chang YC; Huang JL; Hung GU; Chen SA; Chen J Ann Nucl Med; 2015 Nov; 29(9):772-8. PubMed ID: 26194143 [TBL] [Abstract][Full Text] [Related]
45. Predicting Clinical and Echocardiographic Response After Cardiac Resynchronization Therapy With a Score Combining Clinical, Electrocardiographic, and Echocardiographic Parameters. Bernard A; Menet A; Marechaux S; Fournet M; Schnell F; Guyomar Y; Leclercq C; Mabo P; Fauchier L; Donal E Am J Cardiol; 2017 Jun; 119(11):1797-1802. PubMed ID: 28400028 [TBL] [Abstract][Full Text] [Related]
46. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831 [TBL] [Abstract][Full Text] [Related]
47. The impact of nonsustained ventricular tachycardia on reverse remodeling, heart failure, and treated ventricular tachyarrhythmias in MADIT-CRT. Mittal S; Aktas MK; Moss AJ; McNitt S; Kutyifa V; Steinberg JS; Zareba W J Cardiovasc Electrophysiol; 2014 Oct; 25(10):1082-7. PubMed ID: 24862906 [TBL] [Abstract][Full Text] [Related]
48. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. Higgins SL; Hummel JD; Niazi IK; Giudici MC; Worley SJ; Saxon LA; Boehmer JP; Higginbotham MB; De Marco T; Foster E; Yong PG J Am Coll Cardiol; 2003 Oct; 42(8):1454-9. PubMed ID: 14563591 [TBL] [Abstract][Full Text] [Related]
49. Reduction in life-threatening ventricular tachyarrhythmias in statin-treated patients with nonischemic cardiomyopathy enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). Buber J; Goldenberg I; Moss AJ; Wang PJ; McNitt S; Hall WJ; Eldar M; Barsheshet A; Shechter M J Am Coll Cardiol; 2012 Aug; 60(8):749-55. PubMed ID: 22703927 [TBL] [Abstract][Full Text] [Related]
50. Impact of atrial fibrillation on improvement of functional mitral regurgitation in cardiac resynchronization therapy. van der Bijl P; Vo NM; Leung M; Ajmone Marsan N; Delgado V; Stone GW; Bax JJ Heart Rhythm; 2018 Dec; 15(12):1816-1822. PubMed ID: 30017815 [TBL] [Abstract][Full Text] [Related]
51. Effect of cardiac resynchronization therapy on the risk of ventricular tachyarrhythmias in patients with chronic kidney disease. Daimee UA; Biton Y; Moss AJ; Zareba W; Cannom D; Klein H; Solomon S; Ruwald MH; McNitt S; Polonsky B; Wang PJ; Goldenberg I; Kutyifa V Ann Noninvasive Electrocardiol; 2017 May; 22(3):. PubMed ID: 27629147 [TBL] [Abstract][Full Text] [Related]
52. Comparison of age (<75 Years versus ≥75 Years) to risk of ventricular tachyarrhythmias and implantable cardioverter defibrillator shocks (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). Aktas MK; Goldenberg I; Moss AJ; Huang DT; Kutyifa V; Wang PJ; Brenyo A; McNitt S; Zareba W; Barsheshet A Am J Cardiol; 2014 Dec; 114(12):1855-60. PubMed ID: 25438913 [TBL] [Abstract][Full Text] [Related]
53. Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony. Dominguez-Rodriguez A; Abreu-Gonzalez P; Piccolo R; Galasso G; Reiter RJ Int J Cardiol; 2016 Oct; 221():359-63. PubMed ID: 27404706 [TBL] [Abstract][Full Text] [Related]